StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics total assets

Total assets on the balance sheet at the end of each period.

Immatics's total assets was €485.74M at Jun 30, 2026. For fiscal 2025 it was €562.34M, down 19.2% from the year before. The highest annual figure on record is €696.15M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€562.34M-19.2%
FY2024Dec 31, 2024€696.15M+36.5%
FY2023Dec 31, 2023€509.97M+25.0%
FY2022Dec 31, 2022€407.82M+133.5%
FY2021Dec 31, 2021€174.65M-31.4%
FY2020Dec 31, 2020€254.65M+89.6%
FY2019Dec 31, 2019€134.28M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€485.74M-15.9%
Q4 FY2025Dec 31, 2025€562.34M-10.3%
Q2 FY2025Jun 30, 2025€567.30M-13.1%
Q4 FY2024Dec 31, 2024€696.15M+36.5%
Q3 FY2024Sep 30, 2024€577.23M+40.7%
Q2 FY2024Jun 30, 2024€626.97M+53.7%
Q1 FY2024Mar 31, 2024€653.13M+77.3%
Q4 FY2023Dec 31, 2023€509.97M+192.0%
Q2 FY2023Jun 30, 2023€410.19M+89.5%
Q4 FY2022Dec 31, 2022€407.82M+60.2%
Q2 FY2022Jun 30, 2022€368.30M+174.3%
Q4 FY2021Dec 31, 2021€174.65M–
Q2 FY2021Jun 30, 2021€216.51M–
Q4 FY2020Dec 31, 2020€254.65M–
Q4 FY2019Dec 31, 2019€134.28M–

More Immatics figures

See a number that looks wrong?